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Chicago, IL, USA; and 6InfoTech Oulu, Oulu, FinlandThe kidney vasculature is critical for renal function, but
its developmental assembly mechanisms remain poorly
understood and models for studying its assembly dynamics
are limited. Here, we tested whether the embryonic kidney
contains endothelial cells (ECs) that are heterogeneous
with respect to VEGFR2/Flk1/KDR, CD31/PECAM, and
CD146/MCAM markers. Tie1Cre;R26RYFP-based fate
mapping with a time-lapse in embryonic kidney organ
culture successfully depicted the dynamics of kidney
vasculature development and the correlation of the process
with the CD31D EC network. Depletion of Tie1D or CD31D
ECs from embryonic kidneys, with either Tie1Cre-induced
diphtheria toxin susceptibility or cell surface marker–based
sorting in a novel dissociation and reaggregation
technology, illustrated substantial EC network regeneration.
Depletion of the CD146D cells abolished this EC
regeneration. Fate mapping of green ﬂuorescent protein
(GFP)-marked CD146D/CD31- cells indicated that they
became CD31D cells, which took part in EC structures with
CD31Dwild-type ECs. EC network development depends on
VEGF signaling, and VEGF and erythropoietin are expressed
in the embryonic kidney even in the absence of any external
hypoxic stimulus. Thus, the ex vivo embryonic kidney culture
models adopted here provided novel ways for targeting
renal EC development and demonstrated that CD146D cells
are critical for kidney vasculature development.
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Kidney International (2016) 90, 311–324T he structures performing renal functions are derivedfrom Six2þ nephron progenitors, FoxD1þ stromalprecursors, presumptive collecting duct cells of the
ureteric bud, and endothelial cell (EC) progenitors.1–3 Studies
of nephron differentiation demonstrate a major role for Wnt
signaling in kidney organogenesis. Wnt9b/b-catenin signaling
induces Wnt4 synthesis in the Six2þ cap mesenchyme, where
the Wnt/calcium pathway leads to mesenchyme-to-
epithelium transformation and the formation of renal vesi-
cles. The Wnt9b/planar cell polarity pathway is involved in
the maturation of epithelialized nephrons.4 Pharmacological
inhibitors of glycogen synthase kinase 3b, which is the phos-
phorylating part of the b-catenin destruction complex,
activate the Wnt pathway downstream of b-catenin. The
glycogen synthase kinase 3b inhibitors lithium and 50-bro-
moindirubin-30-oxime (BIO) both induce nephrogenesis in
the embryonic kidney mesenchyme.5,6
Vascularization of the kidney occurs synchronously
with nephrogenesis. Previous studies have shown that
ECs expressing the platelet/endothelial cell adhesion
molecule-1 (PECAM-1/CD31), kinase insert domain protein
receptor (Kdr/VEGFR2/Flk1), and tyrosine kinase with
immunoglobulin-like and epidermal growth factor
(EGF)-like domains 1 (TIE/Tie1) are present in the early
embryonic kidney.7–9 In humans, transition of CD31þ/
CD34þ glomerular ECs into CD31þ/CD34- has been
described.10 Fate mapping of Flk1þ and Tie1þ cells shows that
cells of these lineages constitute the vascular endothelium of
the embryonic kidney.8,11 In chimeric assay, the Tie1- cells are
excluded from the renal vasculature.12 Host-derived Flk1þ
ECs are implicated in vascularization of the grafted embry-
onic kidney.13 Flk1 expression has also been reported in the
ureteric bud (UB), where it may regulate branching
morphogenesis.13,14 The melanoma cell adhesion molecule
(MCAM/Muc18/CD146), which functions as a coreceptor of
Flk1 and is expressed in ECs, including the progenitors, has
not been described in kidney development.15–17 As far as the
origins of the renal endothelium are concerned, the results of
grafting experiments suggest that the murine embryonic
kidney contains EC progenitors that are competent to
vascularize the kidney,13,18 but grafted embryonic kidneys
also attract exogenous vasculature.13,19 In any case, the EC311
bas i c re sea r ch KJ Halt et al.: CD146+ cells and kidney vasculature assemblyprogenitors in the embryonic kidney have still not been
characterized.
We show that the ECs in the mouse embryonic kidney are
heterogeneous with respect to their surface markers and that
the CD146þ cells among them are necessary for microvas-
cular network assembly. A novel approach involving fate
mapping of the green ﬂuorescent protein (GFPþ)/CD146þ/
CD31- cells indicate that these cells differentiate into CD31þ
ECs. In addition, we show that vascular endothelial growth
factor (VEGF) signaling is essential in order to maintain the
EC, whereas the hypoxia response is not critical for EC sur-
vival ex vivo. The ex vivo models demonstrated here provide
ways of targeting the mechanisms of kidney vasculature
assembly.
RESULTS
As judged by Flk1, CD31, and CD146 staining, the embryonic
kidney contains a heterogeneous pool of ECs
At the initiation of kidney organogenesis on embryonic day
(E) 11.5, the ECs are revealed by CD31-staining within the
cortical interstitial stroma (Supplementary Figure S1A and B).Figure 1 | Heterogeneous endothelial cells are present among the C
ureteric bud (UB), cap mesenchyme (CM), and cortical interstitial stroma
arrowhead, arrowhead) among the CIS. (c) CD31-immunoreactivity is stro
Occasional CD31þ adhesions exist in the Flk1þ clusters (concave arrowh
(a–d) Bars ¼ 100 mm. (b0–d0) Bars ¼ 50 mm. E, embryonic day.
312They had then invaded the area adjacent to the Pax2þ cap
mesenchyme and its derivatives by E12.5 (Supplementary
Figure S1C and D) and were present in the presumptive
Bowman capsule assembling the glomerulus by E13.5
(Supplementary Figure S1E and F). Staining of sections of
embryonic kidney at E11.5 with Flk1 and CD31 antibodies
showed that the CD31þ ECs made up a subset of the Flk1þ
cells (Figure 1).
Staining of whole mount embryonic kidneys with CD31
and CD146 antibodies at E11.5 demonstrated a CD31þ EC
network within the cortical interstitial stroma (Figure 2a and b,
Supplementary Figure S2A–C, Supplementary Movie S1).
Clusters of CD146þ/CD31þ cells formed chain-like struc-
tures, but solitary CD146þ/CD31- cells were also observed. By
E12.5, an extensive CD31þ EC network had developed,
whereas the proportion of CD146þ cells had diminished
(Figure 2c and d, Supplementary Figure S2D–F,
Supplementary Movie S2). We conclude that the embryonic
kidney contains a heterogeneous pool of ECs and that some of
them are characterized by being positive for the CD146
marker.IS. (a) Nuclei of an E11.5 embryonic kidney section containing the
(CIS). (b) Flk1 is located in the capillaries and cell clusters (concave
ng in the primitive capillaries but weak in the cell clusters (arrowhead).
ead). (d) Merge. (b0–d0) Magniﬁcations of the areas outlined in b–d.
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Figure 2 | Confocal double immunolocalization of CD31D and CD146D cells in the embryonic kidney. The embryonic kidney rudiment
was dissected at (a,b) E11.5 and (c,d) E12.5 and subjected to whole mount immunostaining with CD31 and CD146 antibodies. (b) At E11.5, CD31
staining revealed a similar pattern to that seen in embryonic sections (Supplementary Figure S1B). The centrally located CD31þ endothelial cells
were also CD146þ and formed chain-like structures (arrowhead, high magniﬁcation in b0), and solitary CD31- but CD146þ cells were also seen
close to the CD31þ endothelial cells (concave arrowheads, high magniﬁcation in b0 0). (d) At E12.5, the CD31þ cells had formed a network inside
the embryonic kidney explant (compare with Supplementary Figure S1D). Some CD31þ endothelial cells showed CD146 immunoreactivity, but
the proportion of CD146þ was diminished compared with the E11.5 explant. (a–d) Bars ¼ 100 mm. (b0, b0 0) Bars ¼ 20 mm. E, embryonic day.
KJ Halt et al.: CD146+ cells and kidney vasculature assembly ba s i c re sea r chDepiction of the renal EC developmental dynamics
We next characterized the dynamics of EC development in
the embryonic kidney by means of time-lapse imaging.
As a proof of this concept, kidneys derived from
Wnt4(EGFP)Cre;R26RYFP/þ mouse embryos were inspected.
The Wnt4þ induced cap mesenchymal cells were depicted as
developing into tubules with Bowman capsule-like structures,
illustrating the feasibility of the setting (Supplementary
Movies S3 and S4).
To achieve visualization of the ECs, we placed kidneys
from E11.5 and E12.5 Tie1Cre;R26RYFP/þ mouse embryos in
the time-lapse culture. The Tie1þ ECs in E11.5 kidneys were
present in the fresh explant and organized into a network
during culture (Supplementary Movie S5). The Tie1þ cells
were motile, migrating along the EC network. The Tie1þ EC
network became more extensive when E12.5 kidneys were
cultured (Supplementary Movie S6). Staining of the cultured
E11.5 kidneys demonstrated a correlation between the CD31
cells and Tie1/YFP expression (Figure 3). This indicates that
organ culture provides a permissive environment forKidney International (2016) 90, 311–324peritubular EC network assembly and that the patterns of the
CD31þ and Tie1/YFPþ cells were correlated.
Depletion of Tie1Cre;R26RYFP/iDTR ECs with diphtheria toxin
We next used Tie1Cre-mediated recombination of the ﬂoxed
Cre-inducible diphtheria toxin receptor (iDTR)20 to achieve
speciﬁc deletion of the Tie1þ ECs from the embryonic kidney.
As a proof of this concept, kidneys from the Wnt4(EGFP)
Cre;R26RYFP/iDTR mouse embryos were cultured in the pres-
ence of diphtheria toxin. YFP enabled illustration of the
efﬁciency of depletion during culture. The Wnt4-expressing
cells were deleted and nephrogenesis ceased, as is the case
upon Wnt4 knock-out, indicating the feasibility of the diph-
theria toxin/iDTR approach (Supplementary Movie S7).
Treatment of the E11.5 Tie1Cre;R26RYFP/iDTR embryonic
kidneys with the diphtheria toxin killed the Tie1Cre;YFPþ
ECs during the ﬁrst 600 minutes of culture (Supplementary
Movie S8). Although the Tie1þ ECs were eradicated by the
end of the culture period, staining still revealed the presence
of a CD31þ EC network (Figure 4). These results raised the313
Figure 3 | Cultured Tie1CreD;R26RYFP/D embryonic kidney explants reveal a Tie1D capillary network corresponding to the CD31
staining. (a) Bright ﬁeld view of a E11.5 kidney explant in culture at 81 hours. The cap mesenchyme has differentiated into epithelial derivatives,
including s-shaped bodies (concave arrowheads) and Bowman’s capsule-like structures (arrowhead). (b) The YFP signal reveals an endothelial
network (landmarked by concave arrowheads). (c) A bright ﬁeld view of the same explant after paraformaldehyde ﬁxation (concave
arrowheads ¼ s-shaped bodies, arrowhead ¼ Bowman’s capsule). (d) CD31 staining shows a similar network to the YFP signal (landmarked by
concave arrowheads). Bars ¼ 200 mm. E, embryonic day.
bas i c re sea r ch KJ Halt et al.: CD146+ cells and kidney vasculature assemblypossibility that putative EC progenitors generate new CD31þ/
Tie-1- ECs that are resistant to diphtheria toxin due to lack of
uninduced expression of iDTR.
CD31D ECs survive in the dissociation-reaggregation and
experimental tubule induction model
Due to the lack of a CD146Cre mouse line, we targeted EC
differentiation via a novel model in which the metanephric
mesenchyme (MM) is dissociated, reaggregated, and induced
to undergo nephrogenesis.21 In this setup, both lithium and
BIO induced the differentiation of Pax2þ cap mesenchyme
derivatives and a CD31þ EC organization (Figure 5a and b).
Thus the dissociation/reaggregation model combined with
Wnt/b-catenin pathway activation provided a novel setup for
addressing EC development in the embryonic kidney.
We then used ﬂuorescence-activated cell sorting (FACS) to
study the CD31þ and CD146þ cells in the dissociated MM.
The results indicated that 1.2% of the cells of the MM were
CD31þ/CD146þ, whereas 5.6% were CD31-/CD146þ
(Figure 6a), providing a further indication of the heterogenic
nature of the ECs in the embryonic kidney.
CD31D cell depletion has a different impact on EC network
formation in the dissociation/reaggregation model from
CD146D cell depletion
Immunomagnetic eradication of the CD31þ cells from the
dissociated MM to a level as low as 0.03% (Figure 6b) still
allowed EC recovery in the reaggregated explants (Figure 7a),314and FACS-mediated depletion of the CD31þ cells provided
the same outcome (Figure 7c).
Since some ECs in the embryonic kidney were positive for
CD146 (Figures 2 and 6), we addressed their signiﬁcance for
EC network assembly by depleting them via the dissociation/
reaggregation model. Strikingly, eradication of the CD146þ
cells by immunomagnetic sorting led to complete perturba-
tion of the CD31þ EC network assembly (Figure 7b), as was
also the situation with FACS-mediated depletion (Figure 7d).
Removal of only the CD146þ/CD31- cells abolished the ability
of the remaining CD31þ cells to form an EC network
(Figure 7e). Furthermore, aggregation of the MM when it
lacked both CD31þ and CD146þ cells showed no EC struc-
tures, whereas the nephrogenic response demonstrated by
Pax2þ tubules was unaffected (Figure 7f).
Mapping the fate of CD146D cells
To reveal the putative cell differentiation cascade from
CD146þ cells to CD31þ cells, we developed a novel fate
mapping setup for the embryonic kidney. Here the meta-
nephric mesenchymal cells were ﬁrst isolated from mouse
embryos in which all the cells were positive for GFP driven by
a constitutively active b-actin promoter and cytomegalovirus
enhancer.22 CD146þ/CD31- cells were extracted from the
GFPþ metanephric mesenchymal cells with FACS and these
GFPþ/CD146þ/CD31- cells were aggregated for culture with
wild-type, nonﬂuorescent metanephric mesenchymal cells.Kidney International (2016) 90, 311–324
Figure 4 | CD31D ECs persist after diphtheria toxin-mediated ablation of Tie1Creþ;R26RYFP/iDTR cells. (a) Bright ﬁeld view of a diphtheria
toxin-treated Tie1Creþ;R26RYFP/iDTR E11.5 kidney explant in culture at 81 hours. The nephrogenic potential of the cap mesenchyme is unaffected,
because s-shaped bodies (concave arrowhead) and Bowman’s capsules (arrowhead) are generated. (b) The diphtheria toxin treatment has
deleted the YFPþ/iDTRþ endothelial cells (ECs). (c) Bright ﬁeld view of the same explant after paraformaldehyde ﬁxation. (d) CD31 staining
reveals an EC network. Bars ¼ 200 mm. E, embryonic day.
Figure 5 | EC development in the dissociation-reaggregation model. (a) Dissociated E11.5 metanephric mesenchyme (MM) reaggregated
and induced with lithium shows CD31þ (red) endothelial cell (EC) network formation and induction of Pax2þ (green) pretubular aggregates.
(b) 50-bromoindirubin-30-oxime–mediated tubulogenesis induction of the dissociated and reaggregated E11.5 MM results in a robust tubular
epithelium generating a response represented by numerous Pax2þ (green) tubular structures with Bowman’s capsule-like structures (arrow-
heads). CD31þ (red) ECs are present among the interstitial tissue. Bars ¼ 200 mm. E, embryonic day.
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Figure 6 | Flow cytometry of dissociated MM. (a) Analysis of pooled E11.5 metanephric mesenchymes (MMs) dissociated and double-labeled
with CD31- allophycocyanin (CD31-APC) and CD146-ﬂuorescein (CD146-FITC); 1.2% of the MM cells are CD31þ/CD146þ and 5.6% are CD31-/
CD146þ. (b) Analysis after immunomagnetic depletion of CD31þ cells indicates effective removal of these cells. A signiﬁcant proportion of the
CD31-/CD146þ cells are retained, however. E, embryonic day.
bas i c re sea r ch KJ Halt et al.: CD146+ cells and kidney vasculature assemblyAnalysis of the chimeric aggregate revealed GFP-positive
cells that were CD31þ and thus had differentiated from the
CD146þ/CD31-/GFPþ cells (Figure 8). This indicates that the
CD31-/CD146þ cells serve as progenitors for CD31þ ECs in
the embryonic kidney.
Given the earlier data showing that the FoxD1þ stromal
progenitors differentiate into a peritubular capillary endo-
thelium,23 we analyzed the relations of the CD31þ and the
CD146þ cells to the FoxD1þ cells by FACS of the dissociated
kidneys from FoxD1EGFPCre;TdTomato E11.5 mouse em-
bryos. A part of the CD146þ and CD31þ cells were labeled by
the FoxD1EGFPCre;TdTomato, indicating that these cells were
derived from the FoxD1þ lineage (Figure 9).
A CD31D EC network assembles ex vivo, but Bowman capsule
remains avascular
Although culture of E11.5 embryonic kidneys in 21% O2
allowed EC network formation (Figure 10a and b), the
developing Bowman capsule-like structures failed to manifest
CD31þ ECs (Figure 10c). Cultured E14.5 kidneys, however, in
which the ECs had already reached the nascent Bowman
capsules (Supplementary Figure S1F), showed the retention of
glomerular CD31þ ECs (Figure 10d).
The development of a Bowman capsule-like structure
advances signiﬁcantly even in the absence of glomerular ECs,
as judged by the presence of foot processes in the inner cells
(Figure 11), which together with nephrin expression
(Figure 10c) suggest differentiation of the podocytes.
The VEGFR inhibitor abolishes CD31D EC network formation
and the hypoxia pathway appears to be dispensable in its
early development
VEGF is a prime candidate for promoting vascularization of
the embryonic kidney ex vivo. Indeed, we found that fresh
E11.5, E12.5, and E13.5 kidneys and cultured E11.5 kidneys
produced VEGF (Figure 12). Inhibition of VEGF receptor
signaling with vatalanib abolished CD31þ EC network
formation in the cultured kidney explants (Figure 13).316Because we observed EC network formation in normoxic
cultures, we speculated that VEGF might not be synthetized
due to reduced O2 and the hypoxia inducible factor (HIF)
pathway. Supporting this, the expression of HIF1a was
diminished and its targets, VEGF and erythropoietin,
remained unchanged in the cultured kidneys relative to fresh
ones (Figure 12). Moreover, only 2 of 102 hypoxia-regulated
genes showed differential expression in cultured MMs when
compared with fresh E11.5 MMs (Supplementary Tables S1
and S2).DISCUSSION
Because the embryonic kidney can be manipulated extensively
ex vivo,21 it provides an attractive setup for vascularization
studies. To our knowledge this study is the ﬁrst to characterize
the dynamic organization of the vascularization of the em-
bryonic kidney and to effectively interfere with ECs via tissue
engineering techniques.
Current knowledge of the vascularization of the kidney is
limited and partly controversial. In earlier studies, the
embryonic kidney was considered to be completely avas-
cular,19,24 but later observations have revealed Tie1þ, Flk1þ,
and CD31þ ECs at an early stage.7–9,13 Moreover, the fate of
the renal ECs in organ culture has yielded contradicting re-
sults, with some reports suggesting their degeneration,13,25,26
while others have demonstrated that the ECs are maintained
in culture.9,27 The mode of renal vascularization appears to be
mainly angiogenic, as seen in chimeric approaches, which
have shown that the renal vascular endothelium is clonal,3,28
but it has not been possible to exclude partially vasculogenic
origin of the renal endothelium. The heterogeneity of the ECs
of the embryonic kidney has been noted with respect to Flk1þ
and CD31þ cells,9 but the signiﬁcances of the various
EC pools have not been resolved, due to a lack of speciﬁc
techniques for targeting the ECs. Hence, characterization of
the cells harboring the capacity to vascularize the embryonic
kidney has remained incomplete.Kidney International (2016) 90, 311–324
Figure 7 | Depletion of ECs from the dissociated MM. (a) Immunomagnetic depletion of CD31þ cells from the E11.5 metanephric
mesenchyme (MM) results in their reappearance in the reaggregated organ as a CD31þ endothelial cell (EC) network (red) after 48 hours
of culture with lithium-mediated induction. The Pax2þ pretubular aggregates (green) were induced as in Figure 5a. (b) Immunomagnetic
depletion of CD146þ cells from the E11.5 metanephric leads to failure of CD31þ EC network assembly, whereas the speciﬁcation of Pax2þ
(green) pretubular aggregates remains intact. (c) Depletion of the CD31þ cells from the E11.5 MM by ﬂuorescence-activated cell sorting
(FACS) leads to reappearance of CD31þ (red) ECs (concave arrowheads). The Pax2þ (green) tubular epithelium was induced by
50-bromoindirubin-30-oxime (BIO). (d) The reaggregated CD146- fraction of an MM does not form any CD31þ cellular structures, but a Pax2þ
(green) tubular epithelium will appears in response to BIO-induction. (e) Removal of CD31-/CD146þ cells results in rudimentary CD31þ
cell clusters (red). (f) FACS-mediated depletion of CD31þ/ CD146þ cells led to complete absence of ECs in the reaggregated MM. Pax2
immunostaining revealed that nephrogenic induction by BIO was not affected by the depletion of ECs. The icons on the left of the
images illustrate the population of ECs being depleted (marked with black rectangle). For reference, see Figure 6a. (a,b,d,f) Bars ¼ 200 mm.
(c,e) Bars ¼ 50 mm. CD31-APC, CD31-allophycocyanin; CD146-FITC, CD146-ﬂuorescein; E, embryonic day.
KJ Halt et al.: CD146+ cells and kidney vasculature assembly ba s i c re sea r chOur results support the advantages of ex vivo techniques
for observing and manipulating the embryonic kidney.
Consistent with the current concept, we observed CD31þ,
Flk1þ, and Tie1þ cells in the embryonic kidney. Furthermore,
we identiﬁed CD146þ cells that were incorporated into
microvascular structures as CD31þ groups and in CD31-
solitary positions outside the microvasculature. Time-lapse
imaging combined with the EC-speciﬁc Tie1Cre;R26RYFPKidney International (2016) 90, 311–324reporter demonstrated the dynamic organization of the
microvascular network being consistent with angiogenic
sprouting. Even though glomerular capillary development
fails in organ cultures of early embryonic kidneys, as noted
earlier,29 podocyte differentiation occurs robustly. Interest-
ingly, the glomerular ECs are maintained in the culture once
they have formed in vivo. Thus, it can be speculated that
blood ﬂow may be required for the guidance of glomerular317
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Figure 9 | Relation of FoxD1D interstitial precursors to renal endothelial cells. (a) An E11.5 FoxD1Cre;TdTomato kidney dissociated and
labeled with CD146 antibody. A signiﬁcant pool of TdTomatoþ (RFP) cells is seen representing the FoxD1þ cells and their descendants. A total of
1.0% of the cells in the kidney are CD146þ, being derived from FoxD1þ stromal precursors. In addition, CD146þ cells originating from lineages
outside the FoxD1 population exist. (b) Similarly, the CD31þ cells show heterogeneous origin with respect to FoxD1þ stromal precursors.
E, embryonic day; PE, phycoerythrin; PerCP, peridinin chlorophyll protein.
=
KJ Halt et al.: CD146+ cells and kidney vasculature assembly ba s i c re sea r chcapillary sprouting. Our results suggest that VEGF signaling is
required for EC development ex vivo, and that VEGF
expression in the kidney explant is independent of any hyp-
oxic stimulus. In terms of cell population relations, the
diphtheria toxin/iDTR approach suggested that Tie1þ cells are
redundant as far as the vascularization of the embryonic
kidney is concerned, because CD31þ ECs were retained after
culture. Because CD31 expression starts prior to Tie1 in
ECs,30 primitive CD31þ/Tie1- cells are perhaps sufﬁcient to
vascularize the kidney to a certain extent. Furthermore,
removal of the CD31þ cells resulted in their reappearance in
the cultured explants, suggesting the existence of a yet more
primitive EC source.
The EC generation capacity of the embryonic kidney
mesenchyme was lost upon CD146þ cell removal, and fate
mapping with GFPþ/CD146þ/CD31- cells demonstrated that
the initially CD31- CD146þ cells were able to gain CD31
expression and be incorporated into EC structures, strongly
suggesting that these cells function as EC progenitors in the
embryonic kidney. Moreover, it can be concluded that the
remaining kidney mesenchymal cells were not competent to
differentiate into ECs, thus pointing to the existence of a
distinct, separable pool of EC progenitors in the embryonic
kidney. Tracing of the fate of the FoxD1þ cells showed,
however, that the FoxD1þ stromal progenitors may still be
able to turn into an EC lineage prior to E11.5, but they lose
this competence until E11.5. A comparable stage-dependent
restriction of differentiation capacity has been demonstrated
in Osr1þ intermediate mesodermal cells.31
The vascular ECs of the normal adult human kidney
express CD146, but increases in vascular expression and de
novo expression in tubular cells can occur in nephropathies.32Figure 8 | Differentiation of CD146D cells to CD31D cells. Fluorescen
dissociated metanephric mesenchyme of GFPþ mice gain CD31-express
cells. Green signal—endogenous expression of green ﬂuorescent protein
Three repetitions of the experiment. (j–l) High resolution image of a cell d
presented in g–i). (a–i) Bars ¼ 50 mm. (j–l). Bars ¼ 20 mm.
Kidney International (2016) 90, 311–324Moreover, increased concentrations of soluble CD146 are
observed in patients with chronic renal failure, correlating
with EC injury markers.33 A mouse model of renal ischemia/
reperfusion injury has revealed that cell therapy with human
bone marrow–derived stem cells increases survival via
regeneration of the peritubular vasculature. The infused cells
are incorporated into the renal endothelium and interstitium,
where they gain expression of CD146 and secrete angiogenic
factors.34 Hence intrinsic and therapeutic regeneration of an
endothelial injury in the adult kidney may occur in an
embryonic CD146þ cell-dependent manner, as described in
our study, indicating that cell therapeutic avenues utilizing
CD146þ EC progenitors can enhance renal function by
promoting maintenance of the vasculature and thus main-
taining the highly perfusion-dependent tubular cell activity
and improving survival.
MATERIALS AND METHODS
Animals
The animal care and procedures were in accordance with the Finnish
national legislation for the use of laboratory animals, the European
Convention for the protection of vertebrate animals (ETS 123) and
EU Directive 86/609/EEC. In this study, CD-1, C57BL6, GFP,22
Tie1Cre,35 iDTR,20 Wnt4(EGFPCre),36 FoxD1EGPCre;TdTomato,23
and R26RYFP reporter mice were used. The genotyping of the
embryos was performed by polymerase chain reaction of material
from the embryonic tail. The appearance of the vaginal plug was
considered to represent E0.5.
Preparation of the tissues and dissociation of the explant to
single cells
Dissection of the embryonic kidney has been described elsewhere.37
The metanephric mesenchymes were dissociated by incubating theirce-activated cell sorting–isolated CD31-/CD146þ cells from the
ion in tissue reaggregated with wild-type metanephric mesenchymal
(GFP), red—immunostaining with CD31 antibody. (a–c, d–f, and g–i)
ouble positive for GFP and CD31 (lower magniﬁcation of the same cell
319
Figure 10 | Formation of the renal corpuscle in culture. (a) Cryosection from an E11.5 kidney cultured for 24 hours and stained for Pax2
(green), CD31 (red), and nuclei (blue). CD31þ endothelial cells (ECs) are retained among the Pax2- stromal cells. Ureteric bud (UB) branching
occurs (asterisk) and the tips of the UB are adjoined by the Pax2þ cap mesenchyme (concave arrowhead), which differentiates to a pretubular
aggregate (arrowhead). (b) Confocal view of a whole mount E11.5 kidney cultured for 48 hours and stained for E-cadherin (green, epithelial
structures) and CD31 (red). The UB has formed several branches and induced the cap mesenchyme to undergo mesenchyme-to-epithelium
transformation to give rise to s-shaped bodies (arrowhead) via a pretubular aggregate stage (concave arrowhead). (b0) A high magniﬁcation
view of the area outlined in (b). A pretubular aggregate (concave arrowhead) commences expression of E-cadherin as a sign of the initiation of
mesenchyme-to-epithelium transformation. The distal end of the s-shaped body (arrowhead) becomes continuous with the UB (asterisk),
whereas the proximal end (arrow) consists of the presumptive parietal and visceral epithelial cells of Bowman’s capsule. The CD31þ ECs are
located adjacent to the pretubular aggregate and the s-shaped body but do not invaginate into the proximal cleft of the s-shaped body.
(c) A high-magniﬁcation confocal microscopic view of the Bowman’s capsule-like structure from an E11.5 kidney cultured for 7 days shows
round, packed nephrinþ (green) cells, suggesting advanced podocyte differentiation. The CD31þ (red) ECs remain outside the nephrinþ
clusters, but (d) part of the CD31þ glomerular tuft (red) is retained among nephrinþ (green) podocytes in an E14.5 kidney cultured for 4 days.
(a) Bar ¼ 100 mm. (b) Bar ¼ 200 mm. (b0, c, and d) Bars [ 50 mm. E, embryonic day.
bas i c re sea r ch KJ Halt et al.: CD146+ cells and kidney vasculature assemblypool for 45 minutes in 40 ml of 2 mg/ml collagenase I (Worthington,
Lakewood, NJ) and 35 ml DNAse I (Fermentas, Burlington, Ontario)
diluted in 280 ml of physiological buffer at 37 C and disrupting the
tissue with 50 repeated pipette suctions every 15 minutes. After
incubation, the collagenase activity was inhibited by adding 600 ml
of the full medium. The cells were pelleted for 4 minutes at
1380g and suspended in phosphate-buffered saline (PBS) with
0.5% fetal bovine serum (FBS). The suspension was centrifuged for
4 minutes at 1380g and the pellet resuspended in 100 ml of PBS with
0.5% FBS.
Immunomagnetic- and ﬂuorescence-activated cell sorting
The MM cells in 100 ml of PBS with 0.5% FBS were labeled with anti-
CD31-biotin (1:11; Miltenyi Biotech, Bergisch Gladbach, Germany),
anti-biotin-allophycocyanin (Miltenyi Biotech), anti-biotin-Micro320Beads (1:11; Miltenyi Biotech), and anti-CD146-MicroBeads (Mil-
tenyi Biotech) according to the manufacturer’s instructions. The
depletion was carried out with a VarioMACS separator and LS col-
umns (Miltenyi Biotech).
For the FACS, the MM cells were suspended in 100 ml of PBS with
0.5% FBS and labeled with anti-CD31-allophycocyanin (Miltenyi
Biotech), anti-CD146-ﬂuorescein (Miltenyi Biotech), and anti-
CD146-phycoerythrin (Miltenyi Biotech) for 10 minutes at 4 C.
They were then pelleted at 1380g for 4 minutes and washed once
with 500 ml of PBS and 0.5% FBS, pelleted again at 1380g for 4
minutes and resuspended in 500 ml Dulbecco’s modiﬁed Eagle’s
medium (without phenol red) with 0.5% FBS. The cells were sorted
with the FACS Calibur ﬂow cytometer (BD Biosciences, Franklin
Lakes, NJ) and collected in 500 ml of medium. The cells from
the FoxD1Cre;TdTomato embryonic kidneys were stained withKidney International (2016) 90, 311–324
Figure 11 | Ultrastructure of the Bowman’s capsule-like structure
of the cultured kidney. Transmission electron microscopic view
of the Bowman’s capsule-like structure shows a cluster of round
cells (concave arrowheads) packed into a dense structure that is
delineated by ﬂattened cells resembling the parietal epithelial
layer of Bowman’s capsule (arrowheads). The inset shows a high
magniﬁcation view inside a Bowman’s capsule-like structure. The
foot process morphogenesis (concave arrowheads) was consistent
with podocyte differentiation. Bars ¼ 10 mm in main image and
1 mm in the inset.
KJ Halt et al.: CD146+ cells and kidney vasculature assembly ba s i c re sea r chCD146-Peridinin Chlorophyll Protein Complex-Cyanin5.5 (BD
Biosciences) and CD31-phycoerythrin-Cy7 (BD Biosciences)
antibodies. They were then analyzed with a BD FACS Aria ﬂow
cytometer.Figure 12 | Expression of hypoxia-related proteins in the
embryonic kidney. Lysates from freshly dissected E11.5, E12.5, and
E13.5 kidneys and E11.5 kidneys cultured in 21% O2 for 24 and 48
hours were collected and blotted for hypoxia-inducible factor 1a
(HIF1a), vascular endothelial growth factor (VEGF), and erythropoietin
(EPO). The fresh E11.5, E12.5, and E13.5 kidneys expressed HIF1a,
which showed slightly diminished expression in those cultured for
24 and 48 hours. Both fresh and cultured kidneys express EPO
and VEGF in equal amounts. Tubulin was used as a control.
E, embryonic day.
Kidney International (2016) 90, 311–324Reaggregation of the cells
The MM cells undergoing lithium-mediated induction of nephro-
genesis were pelleted at 1380g for 20 minutes in medium supple-
mented with 100 ng/ml recombinant human ﬁbroblast growth factor
2 (PeproTech, Rocky Hill, NJ) and 50 ng/ml recombinant human
bone morphogenetic protein 7 (Insight Biotechnology, Middlesex,
UK). The pellet was retained in the incubator for 2 hours prior to
tissue culture. The MM cells undergoing induction with BIO (GSK-3
Inhibitor IX, Calbiochem; EMD Millipore, Billerica, MA) were
centrifuged for 20 minutes at 1380g in full medium supplemented
with 5 mM BIO. After centrifugation, the pellet was kept in the
incubator overnight prior to transfer to the Trowell culture.
Tissue culture
The whole kidney explants and reaggregated MM cells were cultured
at 37 C and 5% CO2 in Dulbecco’s modiﬁed Eagle’s medium þ
GlutaMAX (5.56 mM glucose, 1 mM pyruvate) supplemented with
10% FBS and 0.5% penicillin-streptomycin on a polycarbonate ﬁlter
(pore size 1.0 mm; Whatman, Maidstone, UK) supported by a metal
grid. In lithium induction, lithium chloride (3 ml 5M LiCl/1 ml
media)5 was added in the culture media. Vatalanib (1 mM; Selleck
Chemicals, Houston, TX) was used as a VEGFR inhibitor. The
embryonic spinal cord was used as a tubule inducer tissue in the
microarray analysis.38
Immunostaining
The samples were ﬁxed with 4% paraformaldehyde or methanol for
whole mount staining. For the cryosectioning, the explants were
incubated on ice in 15% sucrose/PBS, 30% sucrose/PBS, 1/1 mixture
of 30% sucrose/PBS, and optimal cutting temperature compound
(Tissue-Tek, Sakura Finetek USA, Torrance, CA) for 30 minutes in
each and 5 minutes in optimal cutting temperature compound and
mounted in plastic containers in which they were frozen in liquid
nitrogen. The sections (5 mm cut with Leica Cryotome CM3050S;
Leica, Biosystems, Buffalo Grove, IL) were dried for 1 hour at room
temperature and ﬁxed for 5 minutes in 100% ethanol at –20 C
followed by drying at room temperature for 30 minutes. The sections
were incubated in PBS supplemented with 20% goat serum and
20 mM glycine for 1 hour. The primary antibodies were diluted in
PBS supplemented with 1% FBS and 20 mM glycine and incubated
for 1 hour at room temperature. Rat anti-mouse-CD31 IgG
(BD Pharmingen, San Diego, CA), rat anti-mouse Flk-1 (BD Phar-
mingen), rabbit anti-mouse-Pax2 IgG (Covance, Princeton, NJ),
mouse anti-mouse-E-cadherin IgG (BD Pharmingen), CD31-biotin
(Miltenyi Biotech), CD146-ﬂuorescein (Miltenyi Biotech), and rab-
bit anti-mouse nephrin (gift from Karl Tryggvason) were used as the
primary antibodies. The sections were washed with PBS 3 times for
15 minutes, and the secondary antibodies, diluted in PBS supple-
mented with 1% FBS and 20 mM glycine, were applied and
incubated for 1 hour at room temperature. Alexa Fluor 488 anti-
rabbit-IgG (Invitrogen, Thermo Fisher Scientiﬁc, Waltham, MA),
Alexa Fluor 546 anti-rat-IgG, Alexa Fluor 488 anti-mouse-IgG, and
Texas Red-coupled streptavidin (Vector Laboratories, Burlington,
CA) served as the secondary antibodies. The sections were washed
with PBS 3 times. Hoechst was used as the nuclear marker. The
samples were mounted with ImmuMount (Thermo Fisher Scientiﬁc).
Western blot analysis
Snap-frozen embryonic kidneys were lysed in 25 mM Tris-HCl (pH
7.5), 75 mM NaCl, and 0.25% NP-40 and centrifuged. Protein
concentrations in the supernatants were determined by the Bradford321
Figure 13 | Effect of the VEGF-receptor inhibitor on EC development. (a) An E11.5 kidney explant cultured for 48 hours and stained for
E-cadherin (green) to reveal the ureteric bud and epithelialized capmesenchyme derivatives and CD31 (red) to locate the endothelial cells (ECs). A
CD31þ EC network has been established. The ureteric bud shows a typical branched pattern and mesenchyme-to-epithelium transformation is
evidenced by the presence of E-cadherinþ tubules (arrowheads). (b) A vatalanib-treated kidney explant shows an absence of a CD31þ endothelial
cells. Ureteric bud morphogenesis and mesenchyme-to-epithelium transformation (arrowheads) occur as in the control. Bars ¼ 200 mm.
E, embryonic day; VEGF, vascular endothelial growth factor.
bas i c re sea r ch KJ Halt et al.: CD146+ cells and kidney vasculature assemblymethod (Bio-Rad Protein Assay, Bio-Rad, Hercules, CA). Each
sample (100 mg) was submitted to sodium dodecyl sulfate–
polyacrylamide gel electrophoresis and blotted onto Immobilon-P
membranes (Millipore). The membranes were incubated with
Tris-buffered saline with 5% nonfat dry milk and probed with
anti-HIF-1a (NB100-479; Novus Biologicals, Littleton, CO),
anti-VEGF (BFD31; NeoMarkers, Fremont, CA), anti-erythropoietin
(AB-286-NA; R&D Systems, Minneapolis, MN), and anti-a-tubulin
(T-6199; Sigma-Aldrich, St. Louis, MO) antibodies, which were
detected with horseradish peroxidase–conjugated secondary
antibodies (Dako, Carpinteria, CA) and enhanced chem-
iluminescence detection reagents (Thermo Fisher Scientiﬁc).
RNA extraction and Affymetrix GeneChip probe arrays
Total RNA was isolated from frozen fresh MMs, and MMs were
cultured for 48 and 96 hours with RNeasy Mini Kit (Qiagen, Hilden,
Germany). Affymetrix Mouse Genome 430 2.0 arrays were used in
hybridization. Three replicates per time point were performed.
Microscopy
An Olympus IX81 microscope with Olympus Fluoview (version 3.0a
software; Shinjuku, Japan) and a Zeiss LSM 780 microscope with
Zen software (Oberkochen, Germany) were used in the confocal
imaging. Epiﬂuorescent images were obtained with an Olympus
BX51WI microscope with Cell
ˇ
M software. The transmission elec-
tron microscopy samples were ﬁxed in 1% glutaraldehyde and 4%
formaldehyde in 0.1 M phosphate buffer, postﬁxed in 1% osmium
tetroxide, dehydrated in acetone, and embedded in LX-112 (Ladd
Research Industries, Williston, VT).
Time-lapse video microscopy
The embryonic kidney explants were placed on permeable polyester
membranes with pores of diameter 0.4 mm. Dulbecco’s modiﬁed
Eagle’s medium without phenol red (Gibco, Thermo Fisher)
supplemented with 10% FBS and 0.5% penicillin-streptomycin
was used as a culture medium. The membranes were put on
Transwell plates (Costar 3450; Corning, Corning, NY) and placed in
a microscope stage incubator. TControl Basic 2.3 software (Okolab,322Pozzuoli, NA, Italy) was used to keep the humidiﬁed air inside the
incubator at 37 C with 5% CO2. An Olympus IX81 inverted
microscope with an Olympus XM-10 digital camera and Cell
ˇ
P
software was used to record epiﬂuorescent images at 20-minute
intervals.
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Figure S1. CD31þ ECs accompany the nephron-generating tissue
in vivo. (A) Nuclear staining of a sagittal section from an E11.5 mouse
embryo at the level of the embryonic kidney. The embryonic kidney
is assembled from an epithelial ureteric bud (UB) arising from the
Wolfﬁan duct (WD), a cap mesenchyme (CM), and a cortical interstitial
stroma (CIS). (B) Both the UB and CM express Pax2 (green), but the
CIS does not. The CD31þ endothelial cells (ECs) (red, concave
arrowheads) reside among the CIS. (C) By E12.5 the UB has branched
to form the dichotomous pattern of a luminous epithelial tube
(asterisk). The tips of the UB are adjoined by the CM (arrowhead),
which undergoes mesenchyme-to-epithelium transformation
ventrally via a pretubular aggregate stage (concave arrowhead) toKidney International (2016) 90, 311–324
KJ Halt et al.: CD146+ cells and kidney vasculature assembly ba s i c re sea r chgive rise to a renal vesicle (arrow). (D) The CD31þ (red) ECs remain
among the Pax2- CIS surrounding the UB (asterisk), CM (arrowhead)
and its derivatives, the pretubular aggregate (concave arrowhead),
and the renal vesicle (arrow). (E) At E13.5 the UB continues iterative
branching, inducing self-renewing CM (arrowhead) to differentiate
into renal vesicles (arrows). The renal vesicles formed earlier have
undergone morphogenesis to form s-shaped tubules (asterisks) that
now reside in a subcortical position. (F) The CD31þ ECs (red) invag-
inate into the proximal clefts of the s-shaped tubules (concave
arrowheads) (arrowhead ¼ CM, arrows ¼ renal vesicles, asterisks ¼
s-shaped tubules). Bars ¼ 100 mm. E, embryonic day.
Figure S2. Maximum intensity projections of CD31- and CD146
signals in E11.5 and E12.5 whole mount embryonic kidneys. (A) The
CD146þ cells (green) are distributed in a network and as individual
cells at E11.5, and (D) they have become organized in a more discrete
manner by E12.5. (B) The CD31þ cells form a network at E11.5, and
(E) this network is extensively present at E12.5. (C) The merged view
of the E11.5 kidney demonstrates that the CD146þ cells (green) are
located in the central region of the kidney explant, whereas the
CD31þ cells have a more peripheral location. (F) At E12.5 the CD31þ
occupy the whole kidney explant and the peripheral zone contains
no CD146þ cells. E, embryonic day.
Movie S1. Confocal Z-scan through an E11.5 kidney. CD146þ cells
(green) are enriched in the central area of the explant. A CD146 signal
is occasionally seen in solitary CD31- cells, whereas many of the
clustered or aligned CD146þ cells possess a CD31 signal (red). The
CD146- but CD31þ cells are generally more elongated in shape and
form sprouts connecting them to each other (e.g., in the upper right
part at the beginning of the movie). E, embryonic day.
Movie S2. Confocal scan through an E12.5 kidney. The CD31þ
endothelial cell network has become organized into an extensive
network. Some of the cells in the network are CD146þ, and there is also
a certain proportion of solitary CD146þ/CD31- cells. E, embryonic day.
Movie S3. Nephrogenesis in a time-lapse setup. An E11.5 whole
kidney explant from a Wnt4(EGFPCre);R26RYFP/þ embryo. Wnt4
activation results in YFP activation in the induced cap mesenchyme,
which undergoes mesenchyme-to-epithelium transformation. The
epithelialized descendants of the Wnt4þ cells organize themselves
into complex tubular structures. E, embryonic day.
Movie S4. Bowman’s capsule-like structure formation in a time-lapse
setup. Descendants of the Wnt4þ cells generate a Bowman’s capsule-
like structure. A high magniﬁcation of the same sample as in Movie S3.
The YFPþ cells are organized into tubular structures with Bowman’s
capsule-like structures, indicating that Wnt4þ-induced cap mesen-
chyme derivatives give rise to both the parietal and visceral epithelial
layers of Bowman’s capsule.
Movie S5. Fate mapping of endothelial cells in an E11.5 kidney
culture. An E11.5 Tie1Creþ;R26RYFP/þ kidney culture. (Left) Bright ﬁeld.
(Middle) YFP signal. (Right) Merge. The counter shows culture time in
minutes. The ureteric bud branches from the initial stage to induce
the translucent cap mesenchyme to segregate (700 minutes) and
differentiate into renal vesicles (1440 minutes) and s-shaped bodies
(1980 minutes). The YFPþ endothelial cells become organized into a
continuous capillary network surrounding the ureteric bud and cap
mesenchyme derivatives. The YFPþ endothelial cells show high
motility along the tracks formed by the capillaries. E, embryonic day.
Movie S6. Fate mapping of the endothelial cells in an E12.5 kidney
culture. An E12.5 Tie1Creþ;R26RYFP/þ kidney culture. The panels and
counter are as in Movie S5. At 0 minutes, the ureteric bud has formed
a third generation of branches and its tips are surrounded by a
translucent cap mesenchyme. The interstitial stroma is the tissue with
a darker appearance that surrounds the ureteric bud and cap
mesenchyme. The ureteric bud continues branching and induces theKidney International (2016) 90, 311–324cap mesenchyme to undergo mesenchyme-to-epithelium
transformation and form nephrons. The YFP signal reveals the
establishment of an endothelial cell network that forms loops which
in some areas are seen to send projections from the perimeter to the
center of the loop. The extreme peripheral zone of the explant is
seeded with YFPþ endothelial cells from the subperipheral
endothelial cell network. E, embryonic day.
Movie S7. DT treatment of a Wnt4Creþ; R26RYFP/iDTR kidney. On E12.5,
aWnt4(EGFPCre);R26RYFP/iDTR kidney was placed in a time-lapse culture.
(Left) Control explant. (Right) Diphtheria toxin-treated explant. At the
start of the culture, the induction of nephron differentiation has
already commenced, as demonstrated by Wnt4Cre-driven YFP
expression in the induced cap mesenchyme. The control embryonic
kidney undergoes ureteric bud branching and nephron formation from
the descendants of the YFPþ-induced cap mesenchyme, whereas the
diphtheria toxin-treated kidney shows the disappearance of the
existing YFPþ-induced cap mesenchyme (arrow). Moreover, as soon as
the Wnt4Cre-driven YFP signal appears at the cortex as a sign of the
induction of a new generation of nephrons, the growth of the YFPþ
structure is inhibited. Morphologically, the diphtheria toxin-treated
kidney does not form mesenchyme-derived epithelial tubules, but
ureteric bud branching proceeds. E, embryonic day.
Movie S8. Diphtheria toxin-mediated deletion of Tie1þ endothelial
cells in an E11.5 Tie1Creþ;R26RYFP/iDTR kidney culture. The panels and
counter are as in Movie S5. The YFPþ capillary network is initially
present in both the control and diphtheria toxin-treated kidney
explants (middle column at 0 minutes). At 1260 minutes, as the
capillary network is well established, the diphtheria toxin-treated
explants show an absence of YFPþ capillaries (middle column).
However, as indicated by the bright ﬁeld and merged panels, ureteric
bud branching, mesenchyme-to-epithelium transformation, and
s-shaped body formation occur in the diphtheria toxin-treated
explant in the same way as in the control explant. E, embryonic day.
Table S1. Hypoxia response genes. This table shows the differential
expressed genes under normoxic and hypoxic conditions. (Greijer AE,
van der Groep P, et al. Up-regulation of gene expression by hypoxia
is mediated predominantly by hypoxia-inducible factor 1 (HIF-1).
J Pathol. 2005;206:291–304.)
Table S2. The hypoxia response genes show differential patterns in
kidney mesenchyme induced by spinal cord during time points 0, 48,
and 96 hours. Fold_charge means the differential fold charge
between time points 0 and 48 hours; fold_charge1 means the
differential fold charge between normoxic and hypoxic.
Supplementary material is linked to the online version of the paper at
www.kidney-international.org.
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